Product
IL-17i
1 clinical trial
2 indications
Indication
ArthritisIndication
PsoriaticClinical trial
Assessment of Guselkumab (Tremfya) and IL-17 Inhibitor Therapies in Patients With Psoriatic Arthritis in Routine Clinical Practice; A Prospective, Observational Cohort StudyStatus: Active (not recruiting), Estimated PCD: 2027-12-07